HANNAH BERNADSKY: Open Payments
NPI 1902532039 · WAIPAHU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 21 payments from 11 companies in 2025. Trend: 2023 $1,577 · 2024 $1,698 · 2025 $567
Food & beverage: $567
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $176 |
| Lilly USA, LLC | 2 | $62 |
| Aurinia Pharma U.S., Inc. | 3 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| Ardelyx, Inc. | 2 | $45 |
| Travere Therapeutics, Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
Products named: Kerendia, JARDIANCE, LUPKYNIS, Fabhalta, IBSRELA, VOYXACT, JYNARQUE, ACTHAR.
Industry payments across HI — which companies pay providers there.
